EichorEICHOR
Location: Camden Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Camden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The ED-AWARENESS-2 Trial
NA · Cooper University Hospital/Cooper Medical School of Rowan Un · Washington University School of Medicine · NCT05534243MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Cooper Hospital University Medical Center · National Cancer Institute (NCI) · NCT05564390Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Cooper Hospital University Medical Center · NRG Oncology · NCT05624996Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
Phase 1/Phase 2 · Cooper University Health Care · The Cooper Health System · NCT06510582StrokeNet Thrombectomy Endovascular Platform
NA · Cooper University Hospital · Medical University of South Carolina · NCT06289985Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Cooper University Health Care · Sequenom, Inc. · NCT06643741Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therap
NA · MD Anderson Cancer Center at Cooper · The Cooper Health System · NCT06688422Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Cooper Hospital University Medical Center · Alliance for Clinical Trials in Oncology · NCT06632327Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Our Lady of Lourdes · University of British Columbia · NCT04634240ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Cooper Hospital University Medical Center · Alliance for Clinical Trials in Oncology · NCT06876714A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Phase 2 · Cooper University Hospital · Basking Biosciences, Inc. · NCT06226805Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Cooper Hospital University Medical Center · National Cancer Institute (NCI) · NCT04269902Prevail Global Study
NA · Virtua Our Lady of Lourdes Hospital · Medtronic Vascular · NCT06535854Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
Phase 4 · Cooper University Health Care · University of Michigan · NCT05722002Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095Prehospital Analgesia INtervention Trial (PAIN)
Phase 3 · Cooper University Health Care · Jason Sperry · NCT05437575Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Cooper Hospital University Medical Center · National Cancer Institute (NCI) · NCT05256225A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Phase 2 · Merck Sharp & Dohme LLC · NCT07209111Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · National Cancer Institute (NCI) · NCT07061964Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Cooper Hospital University Medical Center · NRG Oncology · NCT05327686Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Phase N/A · Cooper Hospital UNIV MED CTR. · M.D. Anderson Cancer Center · NCT04739072A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · National Cancer Institute (NCI) · NCT07198074IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
NA · Cooper University Hospital · Duke University · NCT06087029Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · NRG Oncology · NCT05080673Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Phase 2 · MD Anderson Cooper · Iovance Biotherapeutics, Inc. · NCT04614103Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · ECOG-ACRIN Cancer Research Group · NCT04239573
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.